Instructions
for Authors
ONLINE MANUSCRIPT SUBMISSION: An online submission
and tracking service via Internet facilitates a speedy and
cost-effective submission of manuscripts. The full manuscript
has to be submitted online via Bentham's Content Management
System (CMS) at http://bsp-cms.eurekaselect.com/index.php/CPD/
(View
Submission Instructions).
Manuscripts must be submitted by one of the authors of the
manuscript, and should not be submitted by anyone on their
behalf. The principal/corresponding author will be required
to submit a Covering Letter along with the manuscript, on
behalf of all the co-authors (if any). The author(s) will
confirm that the manuscript (or any part of it) has not been
published previously or is not under consideration for publication
elsewhere. Furthermore, any illustration, structure or table
that has been published elsewhere must be reported, and copyright
permission for reproduction must be obtained.
For all online submissions, provide soft copies of all the
materials (main text in MS Word or Tex/LaTeX), figures/illustrations
in TIFF, PDF or JPEG, and chemical structures drawn in ChemDraw
(CDX)/ISISDraw (TGF) as separate files, while a PDF version
of the entire manuscript must also be included, embedded with
all the figures/illustrations/tables/chemical structures etc.
It is advisable that the document files related to a manuscript
submission should always have the name of the corresponding
author as part of the file name, i.e., “Cilli MS text.doc”
,“Cilli MS Figure 1”, etc.
It is imperative that before submission, authors should carefully
proofread the files for special characters, mathematical symbols,
Greek letters, equations, tables, references and images, to
ensure that they appear in proper format.
References, figures, tables, chemical structures etc.
should be referred to in the text at the appropriate place
where they have been first discussed. Figure legends/captions
should also be provided.
A successful electronic submission of a manuscript will be
followed by a system-generated acknowledgement to the principal/corresponding
author. Any queries therein should be addressed to kazim@benthamscience.org
MANUSCRIPTS PUBLISHED: The Journal publishes
peer-reviewed mini- and full-length review articles and research
papers written in English. Single topic/thematic issues may
also be considered for publication.
Single Topic Issues: These special issues are peer-reviewed and may contain invited or uninvited review/mini-review articles. A Single Topic Issue Editor will offer a short perspective and co-ordinate the solicitation of manuscripts between 3-5 (for a mini-hot topic) to 6-10 (for full-length hot topic) from leading scientists. Authors interested in editing a single topic issue in an emerging topic of drug design may submit their proposal to the Editor-in-Chief at cpd@benthamscience.org for consideration.
Conference Proceedings: For proposals to publish conference proceedings in this journal, please contact us at email: proceedings@benthamscience.org.
MANUSCRIPT LENGTH:
Mini-Reviews: Mini-reviews should be 3000-6000 words
excluding figures, structures, photographs, schemes, tables
etc.
Full-Length Reviews: Full-length reviews
should be 8000-40000 words excluding figures, structures,
photographs, schemes, tables etc.
Research Articles: Research articles should
be 4000-8000 words excluding figures, structures, photographs,
schemes, tables etc. There is a quota of 20% of published
Research articles per issue in this journal.
There is no restriction on the number of figures, tables or
additional files e.g. video clips, animation and datasets,
that can be included with each article online. Authors should
include all relevant supporting data with each article (Refer
to Supplementary Material section).
MANUSCRIPT PREPARATION:
The manuscript should be written in English in a clear, direct
and active style. All pages must be numbered sequentially,
facilitating in the reviewing and editing of the manuscript.
For further convenience, our contracted service provider Eureka
Science can provide assistance to authors for the preparation
of manuscripts.
MANUSCRIPT SECTIONS FOR PAPERS: Manuscripts
may be divided into the following sections:
Covering letter
Title
Title page
Abstract
Keywords
Text organization
List of abbreviations (if any)
Conflict of interest
Acknowledgements
References
Appendices
Figures/ Illustrations (if any)
Chemical structures (if any)
Tables (if any)
Supportive/ Supplementary material (if any)
Covering Letter: It is mandatory that a signed covering
letter should also be submitted along with the manuscript
by the author to whom correspondence is to be addressed, delineating
the scope of the submitted article declaring the potential
competing interests, acknowledging contributions from authors
and funding agencies, and certifying that the paper is prepared
according to the 'Instructions for Authors'.
All inconsistencies in the text and in the reference section
and any typographical errors must be carefully checked and
corrected before the submission of the manuscript. The article
should not contain any such material or information that may
be unlawful, defamatory, fabricated, plagiarized, or which
would, if published, in any way whatsoever, violate the terms
and conditions as laid down in the copyright agreement. The
authors acknowledge that the publishers have the legal right
to take appropriate action against the authors for any such
violation of the terms and conditions as laid down in the
copy right agreement. DOWNLOAD
COVERING LETTER
Title: The title of the article should be precise
and brief and must not be more than 120 characters. Authors
should avoid the use of non-standard abbreviations. The title
must be written in title case except for articles, conjunctions
and prepositions.
Authors should also provide a short ‘running title’.
Title, running title, byline, correspondent footnote and keywords
should be written as presented in original manuscript.
Title Page: Title page should include paper
title, author(s) full name and affiliation, corresponding
author(s) names complete affiliation/address, phone, fax,
email and keyword should be written as presented in original
manuscript.
Abstract: The abstract should not exceed
250 words for review and research articles summarizing the
essential features of the article. The use of abbreviations
should be reduced to a minimum and the references should not
be cited in the abstract.
Keywords: Authors must supply up to eight
key words along with their manuscript.
Text Organization: The main text should begin
on a separate page and should be divided into title page,
abstract and the main text. The text may be subdivided further
according to the areas to be discussed, which should be followed
by the Acknowledgement (if any) and Reference sections. For
Research Articles the manuscript should begin with the title
page and abstract followed by the main text, which must be
structured into separate sections as Introduction, Materials
and Methods, Results, Discussion, and Conclusion, List of
Abbreviations, Conflict of Interest Acknowledgements, and
References. The Review article should mention any previous
important old and recent reviews in the field and contain
a comprehensive discussion starting with the general background
of the field. It should then go on to discuss the salient
features of recent developments. The authors should avoid
presenting material which has already been published in a
previous review. The authors are advised to present and discuss
their observations in brief. The manuscript style must be
uniform throughout the text and 10 pt Times New Roman fonts
should be used. The full term for an abbreviation should precede
its first appearance in the text unless it is a standard unit
of measurement. The reference numbers should be given in square
brackets in the text. Italics should be used for Binomial
names of organisms (Genus and Species), for emphasis and for
unfamiliar words or phrases. Non-assimilated words from Latin
or other languages should also be italicized e.g. per
se, et al. etc.
Standard Protocol on Approvals, Registrations,
Patient Consents & Animal Protection: All
clinical investigations must be conducted according to the
Declaration of Helsinki principles. For all manuscripts reporting
data from studies involving human participants, formal review
and approval by an appropriate institutional review board
or ethics committee is required. For research involving animals,
the authors should indicate whether the procedures followed
were in accordance with the standards set forth in the eighth
edition of Guide for the Care and Use of Laboratory Animals
(http://grants.nih.gov/grants/olaw/Guide-for-the-care-and-use-of-Laboratory-animals/;
published by the National Academy of Sciences, The National
Academies Press, Washington, D.C.).
A specific declaration of such approval must be made in the
cover letter and in a stand-alone paragraph at the end of
the Methods section especially in the case of human studies
where inclusion of a statement regarding obtaining the written
informed consent from each subject or subject's guardian is
a must. The original should be retained by the guarantor or
corresponding author. Editors may request to provide the original
forms by fax or email.
Authentication of Cell Lines: The
NIH acknowledges the misidentification and/or cross-contamination
of cell cultures e.g. HeLa cells being used in a research
study as a serious problem. In order to ensure the validation
of the work and proper utilization of resources, it is a prerequisite
that correct reagents be used in studies dealing with established
human (tumor) cell lines that have been cultured for more
than 4 years up to the date of submission of the manuscript.
Cell lines such as short-term cultures of human tumors, murine
cell lines (as a catalog of DNA profiles is not yet available)
and tumor cell lines established in the course of the study
that is being submitted, are presently exempt from this rule.
To minimize the risk of working with misidentified and/or
contaminated cell lines, tests such as isoenzyme analysis,
karyotyping/cytogenetic analysis and, more recently, molecular
techniques of DNA profiling may be carried out to authenticate
cell cultures. These tests may help confirm or establish the
identify profile for a cell line. Bentham Science recommends
that all cell lines be authenticated prior to submitting a
paper for review. Authors are therefore required to provide
authentication of the origin and identity of the cells by
performing cell profiling either in their own laboratory or
by outsourcing an approved laboratory or cell bank. Authentication
is required when a new line is established or acquired, before
freezing a cell line, if the performance of the line is not
consistent or results are unexpected, if using more than one
cell line, and before publication of the study.
The cell lines profile should be cross-checked with the profile
of the donor tissue of other continuous cell lines such as
provided by the authentic data bank such as http://www.dsmz.de/fp/cgi-bin/str.html,
ATCC® etc.
Greek Symbols and Special Characters:
Greek symbols and special characters often undergo formatting
changes and get corrupted or lost during preparation of manuscript
for publication. To ensure that all special characters used
are embedded in the text, these special characters should
be inserted as a symbol but should not be a result of any
format styling (Symbol font face) otherwise they will be lost
during conversion to PDF/XML comprising a list of items relevant
to their specific research design. Chemical equations, chemical
names, mathematical usage, unit of measurements, chemical
and physical quantity & units must conform to SI and Chemical
Abstracts or IUPAC.
All kinds of measurements should be reported only in International
System of Units (SI).
List of Abbreviations: If abbreviations are used
in the text either they should be defined in the text where
first used, or a list of abbreviations can be provided.
Conflict of Interest: Financial contributions
to the work being reported must be clearly acknowledged, as
should any potential conflict of interest under the heading
‘Conflict of Interest’. Authors
must list the source(s) of funding for the study, for each
author, and for the manuscript preparation.
Acknowledgements: All individuals listed as
authors must have contributed substantially to the design,
performance, analysis, or reporting of the work and are required
to indicate their specific contribution. Anyone (individual/company/institution)
who has substantially contributed to the study for important
intellectual content, or who was involved in the article’s
drafting the manuscript or revising must also be acknowledged.
Guest or honorary authorship based solely on position (e.g.
research supervisor, departmental head) is discouraged.
The specific requirements for authorship have been defined
by the International Committee of Medical Journal Editors
(ICMJE; http://www.icmje.org).
Examples of authors' contributions are: 'designed research/study',
'performed research/study', 'contributed important reagents',
'collected data', 'analyzed data', 'wrote paper' etc. This
information must be included in the submitted manuscript as
a separate paragraph under the heading ‘Acknowledgements’.
The corresponding author is responsible for obtaining permission
from all co-authors for the submission of any version of the
manuscript and for any changes in the authorship.
References: References must be listed in the numerical
system (Vancouver). All references should be numbered sequentially
[in square brackets] in the text and listed in the same numerical
order in the reference section. The reference numbers must
be finalized and the bibliography must be fully formatted
before submission.
See below few examples of references listed in the correct
Vancouver style:
Typical Paper Reference:
[1] Boehm M, Nabel EG. Angiotensin-converting enzyme 2-a new
cardiac regulator. N Engl J Med 2002; 347: 1795-7.
[2] SoRelle R. Long reach of the N-terminal of B-type natriuretic
peptide. Circulation 2002; 106: 9059-63.
[3] Leone A. Biochemical markers of cardiovascular damage
from tobacco smoke. Curr Pharm Des 2005; 11: 2199-208.
[4] Meuillet EJ, Mahadevan D, Vankayalapati H, et al.
Specific inhibition of the Akt1 pleckstrin homology domain
by D-3-deoxyphosphatidyl- myo-inositol analogues. Mol Cancer
Ther 2003; 2: 389-99.
Typical Chapter Reference:
[5] Ban Y, Tomer Y. Endocrine diseases. Graves’s
and Hashimoto’s diseases. In: Oksenberg J, Brassat D,
Eds. Immunogenetics of autoimmune disease. Medical Intelligence
Unit. New York: Landes Bioscience and Springer Science-Business
Media 2006; pp. 41-58.
[6] Astrup P. The arterial wall in atherogenesis. In Cavallero
Ed. Atherogenesis. Padua: Piccin Medical Books 1965: pp. 77-92.
Book Reference:
[7] Carlson BM. Human embryology and developmental biology.
3rd ed. St. Louis: Mosby 2004.
[8] Rosai J. Histological typing of tumours of the thymus.
2nd ed. Berlin and Heidelberg: Springer-Verlag 1999.
Edited Book:
[9] Brown AM, Stubbs DW, Eds. Medical physiology. New York:
Wiley 1983.
Conference Paper and Proceedings:
[10] Kimura J, Shibasaki H, Eds. Recent advances in clinical
neurophysiology. Proceedings of the 10th International Congress
of EMG and Clinical Neurophysiology; 1995 Oct 15-19; Kyoto,
Japan. Amsterdam: Elsevier 1996.
[11] Cooper R, Cutler J, Desvigne-Nickens P, et al.
Disparities in coronary heart disease, stroke, and other cardiovascular
diseases in the United States: findings of the National Conference
on Cardiovascular Disease Prevention. Circulation 2000; 102:
3137-47.
[12] Chao JT, Theriault A, Gapor A. Delta-tocotrienol is a
potent inhibitor of monocyte-endothelial cell adhesion. In:
Cutting edge technologies For sustained competitiveness. Proceedings
of the 2001 PI POC International palm Oil Congress, Food Technology
and Nutrition Conference, Kuala Lumpur, Malaysia, Aug. 20-22,
2001; pp. 225-34.
Journal Article on the Internet:
[13] Aylin P, Bottle A, Jarman B, Elliott P. Paediatric cardiac
surgical mortality in England after Bristol: descriptive analysis
of hospital episode statistics 1991-2002. BMJ [serial on the
Internet]. 2004 Oct 9; [cited 2004 October 15]; 329: [about
10 screens]. Available from: http://bmj.bmjjournals.com/cgi/content/full/329/7470/825
[14] NCT01013350. Prospective observational long-term safety
registry of multiple sclerosis patients who have participated
in cladribine clinical trials (PREMIERE). Available at http://clinicaltrials.gov/ct2/show/NCT01013350.
[Accessed 15 April 2011].
Book/Monograph on the Internet:
[15] Donaldson MS, Ed. Measuring the quality of health care
[monograph on the internet]. Washington: National Academy
Press 1999 [cited 2004 Oct 8]. Available from:
http://legacy.netlibrary.com/
[16] Silva ATA. Ed. Development of compounds potentially
active against Helicobacter pylori. [monograph on the internet].
Araraquara: School of Pharmaceutical Science, Universidade
Estadual Paulista 2008 [cited 2010 July 10]. Available from:
http://www.fcfar.unesp.br/posgraduacao/cienciasfarmaceuticas/Disertacoes/2008/antonio_tavora-completo.pdf
[monograph in Portuguese].
Web site/Homepage:
[17] HeartCentreOnline [homepage on the Internet]. Boca Raton,
FL: HeartCentreOnline, Inc.; c2000-2004 [updated 2004 May
23; cited 2004 Oct 15]. Available from: http://www.heartcentralonline.com/
[18] Tuberculosis Antimicrobial Acquisition and Coordinating
Facility (TAACF), Global discovery program for novel anti-tuberculosis
drugs [homepage on the Internet]. The National Institute of
Allergy and Infectious Diseases (NIAID) [cited 2011 Jan10].
Available from: http://www.taacf.org/
Journal with Part/Supplement:
If a journal carries continuous pagination throughout the
volume, then the issue number can be omitted.
Issue with Supplement:
[19] Glauser TA. Integrating clinical trial data into clinical
practice. Neurology 2002; 58(12 Suppl 7): S6-12.
[20] Durandy A, Kaveri SV, Kuijpers TW, et al. Intravenous
immunoglobulins--
understanding properties and mechanisms. Clin Exp Immunol
2009; 158(Suppl 1): 2-13.
Volume with Part:
[21] Abend SM, Kulish N. The psychoanalytic method from an
epistemological viewpoint. Int J Psychoanal 2002; 83(Pt 2):
491-5.
[22] O'Riordan JI, Thompson AJ, Kingsley DP, et al.
The prognostic value of brain MRI in clinically isolated syndromes
of the CNS. A 10-year follow-up. Brain 1998; 121(Pt 3): 495-503.
Issue with Part:
[23] Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright
KC. Development of a large animal model for lung tumors. J
Vasc Interv Radiol 2002; 13(9 Pt 1): 923-8.
[24] Bluestone JA. Costimulation and its role in organ transplantation.
Clin transplant 1996; 10(1 Pt 2): 104-9.
Patent:
[25] Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee.
Flexible endoscopic grasping and cutting device and positioning
tool assembly. United States patent US 20020103498. 2002 Aug.
E-citations:
[26] Citations for articles/material published exclusively
online or in open access (free-to-view) , must contain the
exact Web addresses (URLs) at the end of the reference(s),
except those posted on an author’s Web site unless editorially
essential, e.g. ‘Reference: Available from: URL’.
Some important points to remember:
*All references must be complete and accurate.
*If the number of authors exceeds six then et al.
will be used after three names (the term “et al.”
should be in italics).
*Online citations should include the date of access.
*Journal abbreviations should follow the Index Medicus/MEDLINE.
*Take special care of the punctuation convention as described
in the above-mentioned examples.
*Avoid using superscript in the in-text citations and reference
section.
*Abstracts, unpublished data and personal communications (which
can only be included if prior permission has been obtained)
should not be given in the reference section but they may
be mentioned in the text and details provided as footnotes.
*The authors are encouraged to use a recent version of End
Note (version 5 and above) or Reference Manager (version 10)
when formatting their reference list, as this allows references
to be automatically extracted.
Appendices: In case there is a need to present
lengthy, but essential methodological details, use appendices,
which can be a part of the article. An appendix must not exceed
three pages (Times New Roman, 12 point fonts, 900 max. words
per page).The information should be provided in a condensed
form, ruling out the need of full sentences. A single appendix
should be titled APPENDIX, while more than one can be titled
APPENDIX A, APPENDIX B, and so on.
Figures/Illustrations:
All authors must strictly follow the guidelines below for
preparing illustrations for publication in Current
Pharmaceutical Design. If the figures are found
to be sub-standard, then the manuscripts will be rejected/
and the authors offered the option of figure improvement professionally
by Bentham Publishing Services.
The costs for such improvement will be charged to the authors.
The authors should provide the illustrations as separate files,
as well as embedded in the text file, numbered consecutively
in the order of their appearance. Each figure should include
a single illustration. Each figure should be closely cropped
to minimize the amount of white space surrounding the illustration.
If a figure consists of separate parts, it is important that
a single composite illustration file be submitted, containing
all parts of the figure.
Photographs should be provided with a scale bar if appropriate,
as well as high-resolution component files.
Scaling/Resolution
For Line Art image type, which is generally an image based
on lines and text and does not contain tonal or shaded areas,
the preferred file format is TIFF or EPS, with colour mode
being Monochrome 1-bit or RGB, in a resolution of 900-1200
dpi.
For Halftone image type, which is generally a continuous tone
photograph and contains no text, the preferred file format
is TIFF, with colour mode being or RGB or Grayscale, in a
resolution of 300 dpi.
For Combination image type, which is generally an image containing
halftone in addition to text or line art elements, the preferred
file format is TIFF, with colour mode being or RGB or Grayscale,
in a resolution of 500-900 dpi.
Formats
For illustrations, the following file formats are acceptable:
• Illustrator
• EPS (preferred format for diagrams)
• PDF (also especially suitable for
diagrams)
• PNG (preferred format for photos
or images)
• Microsoft Word (version 5 and above;
figures must be a single page)
• PowerPoint (figures must be a single
page)
• TIFF
• JPEG (conversion should be done using
the original file)
• BMP
• CDX (ChemDraw)
• TGF (ISIS Draw)
Bentham Science does not process figures submitted in GIF
format.
If the large size of TIFF or EPS figures acts as an obstacle
to online submission, authors may find that conversion to
JPEG format before submission results in significantly reduced
file size and upload time, while retaining acceptable quality.
JPEG is a 'lossy' format. However, in order to maintain acceptable
image quality, it is recommended that JPEG files are saved
at High or Maximum quality.
Files should not be compressed with tools such as Zipit or
Stuffit prior to submission as these tools will in any case
produce negligible file-size savings for JPEGs and TIFFs,
which are already compressed.
Please do not:
1. Supply embedded graphics in your word processor (spreadsheet,
presentation) document;
2. Supply files that are optimized for screen use (like GIF,
BMP, PICT, WPG); the resolution is too low;
3. Supply files that are too low in resolution;
4. Submit graphics that are disproportionately large for the
content.
Image Conversion Tools:
There are many software packages, many of them freeware or
shareware, capable of converting to and from different graphics
formats, including PNG.
Good general tools for image conversion include Graphic Converter
on the Macintosh, Paint Shop Pro, for Windows, and ImageMagick,
which is available on Macintosh, Windows and UNIX platforms.
Note that bitmap images (e.g. screenshots) should not be converted
to EPS, since this will result in a much larger file size
than the equivalent JPEG, TIFF, PNG or BMP, with no increase
in quality. EPS should only be used for images produced by
vector-drawing applications such as Adobe Illustrator or CorelDraw.
Most vector-drawing applications can be saved in, or exported
as, EPS format. In case the images have been originally prepared
in an Office application, such as Word or PowerPoint, then
the original Office files should be directly uploaded to the
site, instead of being converted to JPEG or another format
that may be of low quality.
Color Figures/Illustrations:
• The cost for each individual page of color figures/plates/illustrations
is US$ 920.
• Color figures should be supplied in CMYK not RGB colors.
Chemical Structures:
Chemical structures must be prepared in ChemDraw/CDX and
provided as separate file.
Structure Drawing Preferences:
[As according to the ACS style sheet]
Drawing Settings:
Chain angle 120°
Bond spacing 18%
of width
Fixed length 14.4
pt (0.500cm, 0.2in)
Bold width 2.0
pt (0.071cm, 0.0278in)
Line width 1.6
pt (0.021cm, 0.0084in)
Margin width 1.6 pt (0.096cm)
Hash spacing 2.5 pt (0.088cm,
0.0347in)
Text Settings:
Font
Times New Roman/Helvetica
Size 8pt
Under the Preference Choose:
Units points
Tolerances 3 pixels
Under Page Setup Use:
Paper US
letter
Scale
100%
Tables:
•Data Tables should be submitted in Microsoft Word
table format.
•Each table should include a title/caption being explanatory
in itself with respect to the details discussed in the table.
Detailed legends may then follow.
•Table number in bold font i.e. Table 1,
should follow a title. The title should be in small case with
the first letter in caps. A full stop should be placed at
the end of the title.
•Tables should be embedded in the text exactly according
to their appropriate placement in the submitted manuscript.
•Columns and rows of data should be made visibly distinct
by ensuring that the borders of each cell are displayed as
black lines.
•Tables should be numbered in Arabic numerals sequentially
in order of their citation in the body of the text.
•If a reference is cited in both the table and text,
please insert a lettered footnote in the table to refer to
the numbered reference in the text.
•Tabular data provided as additional files can be submitted
as an Excel spreadsheet.
Supportive/Supplementary Material (if any):
We do encourage to append supportive material, for example
a PowerPoint file containing a talk about the study, a PowerPoint
file containing additional screenshots, a Word, RTF, or PDF
document showing the original instrument(s) used, a video,
or the original data (SAS/SPSS files, Excel files, Access
Db files etc.) provided it is inevitable or endorsed by the
journal's Editor.
Supportive/Supplementary material intended for publication
must be numbered and referred to in the manuscript but should
not be a part of the submitted paper. In-text citations as
well as a section with the heading "Supportive/Supplementary
Material" before the "References" section should
be provided. Here, list all Supportive/Supplementary Material
and include a brief caption line for each file describing
its contents.
Any additional files will be linked into the final published
article in the form supplied by the author, but will not be
displayed within the paper. They will be made available in
exactly the same form as originally provided only on our Web
site. Please also make sure that each additional file is a
single table, figure or movie (please do not upload linked
worksheets or PDF files larger than one sheet). Supportive/
Supplementary material must be provided in a single zipped
file not larger than 4 MB.
Authors must clearly indicate if these files are not for publication
but meant for the reviewers'/editors' perusal only.
PERMISSION FOR REPRODUCTION: Published/reproduced material
should not be included unless you have obtained written permission
from the copyright holder, which should be forwarded to the
Editorial Office in case of acceptance of your article for
publication.
For obtaining permission for reproducing any material published
in an article by Bentham Science Publishers, please fill in
the request FORM
and send to cpd@benthamscience.org
for consideration.
AUTHORS AND INSTITUTIONAL AFFILIATIONS: The author
will be required to provide their full names, the institutional
affiliations and the location, with an asterisk in front of
the name of the principal/corresponding author. The corresponding
author(s) should be designated and their complete address,
business telephone and fax numbers and e-mail address must
be stated to receive correspondence and galley proofs.
PAGE CHARGES: No page charges will be levied to authors for the publication of their review articles. For published research articles, however, the publication charges for the first 8 pages will be US$ 55 per page; if the article is more than 8 pages, then charges will be US$ 110 per page for additional pages.
LANGUAGE AND EDITING: Manuscripts submitted
containing many English typographical errors will not be published.
Manuscripts which are accepted for publication on condition
that the written English submitted is corrected, will be sent
a quote by Eureka
Science, a professional language editing company. Authors
from non-English language countries who have poor English
language written skills, are advised to contact the language
editing company prior to submitting their manuscript to the
journal. Please contact Eureka
Science for a language editing quote at e-mail: info@eureka-science.com
stating the total number of words of the article to be edited.
언어 및 편집: 영문 오타가 많은 원고는 출판되지 않을 것입니다. 영문 오타를 없애겠다는 조건으로 받은 원고는 영어 편집 전문회사인 유럽 공동 기술개발 기구로부터 가격 견적서가 보내 질 것입니다. 영어 작문에 어려움이 있는 비영어권 국가의 저자들은 원고를 학술지에 제출하기 전에 영어 편집회사와 접촉할 것을 권합니다. 영어 편집 견적서를 받기 위해서 교정될 원고의 단어수를 적은 메일을 유럽 공동 기술개발 기구 메일인 info@eureka-science.com 로 보내시기 바랍니다.
语言和编辑: 含有很多英文印刷错误的提交稿将不予发表。接受发表的稿件其英文写作应是正确的；专业的语言编辑公司（尤里卡科学），可对稿件的英文润色提供报价。建议非英语国家、且英文写作欠佳的作者在投稿前先与语言编辑公司联系。请与尤里卡科学联系 info@eureka-science.com
EDITION ET LANGUE: Les manuscrits soumis avec plusieurs erreurs typographiques en Anglais ne seront pas publiés en l’état. Les manuscrits sont acceptés pour publication à la condition que l'anglais utilisé soit corrigé après la soumission et seront envoyés pour examen à Eureka Science, une société d'édition de langue professionnelle. Les auteurs en provenance de pays où la langue est différente de l'anglais et qui ont de médiocres compétences en anglais écrit, sont priés de contacter la société d'édition de langue avant de soumettre leur manuscrit à la revue. Merci de contacter Eureka Science à info@eureka-science.com pour un devis en indiquant le nombre total de mot de l’article à éditer.
PROOF CORRECTIONS: Authors will receive page proofs of
their accepted paper before publications. To avoid delays
in publication, proofs should be checked immediately for typographical
errors and returned within 48 hours. Major
changes are not acceptable at the proof stage. If unable to
send corrections within 48 hours due to some
reason, the author(s) must at least send an acknowledgement
on receiving the galley proofs or the article will be published
exactly as received and the publishers will not be responsible
for any error occurring in the published manuscript in this
regard.
The corresponding author will be solely responsible for ensuring
that the revised version of the manuscript incorporating all
the submitted corrections receives the approval of all the
co-authors of the manuscript.
REPRINTS: Each first-named (corresponding) author will
receive electronically five free eprints of their published
article. Printed reprints and e-prints may be ordered from the Publisher prior to publication of the article. First named authors may
also order a personal print and online subscription of the
journal at 50% off the normal subscription rate by contacting
the subscription department at e-mail: subscriptions@benthamscience.org
OPEN ACCESS PLUS: Accepted articles can
be published online for free open access for all to view and
be deposited by the Publishers in PubMed Central. Open access
publishing provides the maximum dissemination of the article
to the largest audience. Authors must pay for this service.
All corresponding authors will be asked to indicate whether
or not they wish to pay to have their paper made freely available
on publication. If authors do not select the Open Access option,
then their article will be published with standard subscription-based
access at no charge.
Bentham Science offers authors the choice of open access publication
of their articles at a fee of US$ 2,900 per
published article which allows indefinite free-to-view online
publication with Bentham Science.
All editors, board members and those authors who have contributed
more than two articles in Bentham Science publications are
entitled to a 40% discount on open access
plus fees.
For more information please contact us at e-mail: openaccess@benthamscience.org
FEATURED ARTICLE: Authors may opt to publicize
their article(s) published with Bentham Science by highlighting
their title(s) both at the journal’s Homepage and the
issue Contents page at a cost of US$ 600.
REVIEWING AND PROMPTNESS OF PUBLICATION:
All papers submitted for publication are immediately subjected
to editorial scrutiny, usually in consultation with members
of the journal’s Editorial Advisory Board and outside
independent reviewers. Every effort will be made to peer review
submitted papers quickly. Papers which are delayed by authors
in revision for more than 30 days will have to be re-submitted
as a new submission. Papers accepted for publication are typeset
and proofs are dispatched to authors for any corrections prior
to final publication.
QUICK TRACK Publication: For this journal an optional fast publication fee-based service called QUICK TRACK is available to authors for their submitted manuscripts. Authors who opt for this fee-based service do not have to pay any additional page charges or charges for the improvement of figures (if required).
QUICK TRACK allows online publication within 1 week of receipt of the final approved galley proofs from the authors. Similarly the manuscript can be published in the next forthcoming PRINT issue of the journal. The total publication time, from date of first receipt of manuscript to its online publication is 10 weeks, subject to its acceptance by the referees and modification (if any) by the authors within one week.
Authors who have availed QUICK TRACK service in a BSP journal will be entitled for an exclusive 30% discount if they again wish to avail the same services in any Bentham journal.
Corresponding authors who opt for QUICK TRACK will receive 25 free e-reprint tokens for their manuscripts.
For more information please contact the Editorial Office by
e-mail at cpd@benthamscience.org
COPYRIGHT: Authors who publish in Bentham Science
print & online journals will transfer copyright to their
work to Bentham Science Publishers. Submission of a manuscript
to the respective journals implies that all authors have read
and agreed to the content of the Covering Letter or the Terms
and Conditions. It is a condition of publication that manuscripts
submitted to this journal have not been published and will
not be simultaneously submitted or published elsewhere. Plagiarism
is strictly forbidden, and by submitting the article for publication
the authors agree that the publishers have the legal right
to take appropriate action against the authors, if plagiarism
or fabricated information is discovered. By submitting a manuscript
the authors agree that the copyright of their article is transferred
to the publishers if and when the article is accepted for
publication. Once submitted to the journal, the author will
not withdraw their manuscript at any stage prior to publication.
Plagiarism Prevention: Bentham Science Publishers
use the iThenticate software to detect instances of overlapping
and similar text in submitted manuscripts. iThenticate software
checks content uploaded by a journal editorial office against
a database of periodicals, the Internet, and a comprehensive
article database. It generates a similarity report, including
the percentage overlap between the uploaded article and published
material. Any instances of content overlap are treated according
to a journal’s peer review integrity statement and the
policies recommended by the editorial Committee. You are assured
that the publisher, where you are submitting your manuscript,
is committed to actively combating plagiarism and publishing
original research.
E-Pub Ahead of Schedule: Bentham Science
Publishers are pleased to offer electronic publication of
accepted papers prior to scheduled publication. These peer-reviewed
papers can be cited using the date of access and the unique
DOI number. Any final changes in manuscripts will be made
at the time of print publication and will be reflected in
the final electronic version of the issue. Articles ahead
of schedule may be ordered by pay-per-view at the relevant
links by each article stated via the E-Pub
Ahead of Schedule
Disclaimer: Articles appearing in E-Pub Ahead-of-Schedule
sections have been peer-reviewed and accepted for publication
in this journal and posted online before scheduled publication.
Articles appearing here may contain statements, opinions,
and information that have errors in facts, figures, or interpretation.
Accordingly, Bentham Science Publishers, the editors and authors
and their respective employees are not responsible or liable
for the use of any such inaccurate or misleading data, opinion
or information contained in articles of the E-Pub Ahead-of-Schedule.
|
